Blackstone Inc
FOLD

Blackstone Inc’s Amicus Therapeutics FOLD Stock Holding History

Blackstone Inc’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.46M Sell
170,209
-2,403,995
-93% -$34.5M 0.01% 190
2025
Q4 		$36.7M Buy
2,574,204
+107,100
+4% +$1.05M 0.14% 59
2025
Q3 		$19.4M Hold
2,467,104
– – 0.08% 73
2025
Q2 		$14.1M Hold
2,467,104
– – 0.06% 77
2025
Q1 		$20.1M Hold
2,467,104
– – 0.08% 60
2024
Q4 		$23.2M Hold
2,467,104
– – 0.11% 58
2024
Q3 		$26.3M Hold
2,467,104
– – 0.11% 54
2024
Q2 		$24.5M Hold
2,467,104
– – 0.1% 57
2024
Q1 		$29.1M Hold
2,467,104
– – 0.12% 58
2023
Q4 		$35M Buy
+2,467,104
New +$28M 0.16% 50

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Blackstone Inc's FOLD Position: Q1 2026 in Review

Blackstone Inc reduced its Amicus Therapeutics (FOLD) stake by 93% in Q1 2026, selling an estimated $34.5M and leaving 170,209 shares worth $2.46M. The position accounts for 0.01% of the portfolio, ranked #190.

Blackstone Inc first reported a position in FOLD in Q4 2023 and has held it in 10 quarters since. The position peaked at $36.7M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Blackstone Inc held 170,209 shares of Amicus Therapeutics worth $2.46M as of Q1 2026.
  • Blackstone Inc sold 2,403,995 Amicus Therapeutics shares in Q1 2026, an estimated $34.5M.
  • Amicus Therapeutics made up 0.01% of Blackstone Inc's portfolio in Q1 2026, its #190 holding.
  • Blackstone Inc first reported a position in Amicus Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • Blackstone Inc's Amicus Therapeutics position peaked at $36.7M in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Blackstone Inc's 13F filing for Q1 2026, filed 15 May 2026.